382 related articles for article (PubMed ID: 19856714)
21. (11)C-hydroxyephedrine positron emission tomography in the postoperative management of pheochromocytoma and paraganglioma.
Yamamoto S; Wassberg C; Hellman P; Sundin A
Neuroendocrinology; 2014; 100(1):60-70. PubMed ID: 25012453
[TBL] [Abstract][Full Text] [Related]
22. [Imaging methods in diagnosis of pheochromocytoma].
Neumann K; Langer R
Zentralbl Chir; 1997; 122(6):438-42. PubMed ID: 9334109
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytomas and Hypertension.
Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
[TBL] [Abstract][Full Text] [Related]
24. Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge.
Cohen DL; Fraker D; Townsend RR
Ann N Y Acad Sci; 2006 Aug; 1073():47-51. PubMed ID: 17102071
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
Jochmanová I; Lazúrová I
Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
[TBL] [Abstract][Full Text] [Related]
26. Pheochromocytoma and abdominal paraganglioma.
Renard J; Clerici T; Licker M; Triponez F
J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of pheochromocytoma management in the laparoscopic era.
Solorzano CC; Lew JI; Wilhelm SM; Sumner W; Huang W; Wu W; Montano R; Sleeman D; Prinz RA
Ann Surg Oncol; 2007 Oct; 14(10):3004-10. PubMed ID: 17690941
[TBL] [Abstract][Full Text] [Related]
28. Bilateral pheochromocytoma in pregnancy heralding multiple endocrine neoplasia syndrome IIA. A case report.
Tewari KS; Steiger RM; Lam ML; Rutgers JK; Berkson RA; DiSaia PJ
J Reprod Med; 2001 Apr; 46(4):385-8. PubMed ID: 11354841
[TBL] [Abstract][Full Text] [Related]
29. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
30. Metastatic pheochromocytoma and paraganglioma.
Angelousi A; Kassi E; Zografos G; Kaltsas G
Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
[TBL] [Abstract][Full Text] [Related]
32. Phaeochromocytomas and functional paragangliomas: clinical management.
Plouin PF; Amar L; Lepoutre C
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
[TBL] [Abstract][Full Text] [Related]
33. A "pheo" lurks: novel approaches for locating occult pheochromocytoma.
Pacak K; Goldstein DS; Doppman JL; Shulkin BL; Udelsman R; Eisenhofer G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3641-6. PubMed ID: 11502790
[TBL] [Abstract][Full Text] [Related]
34. Pheochromocytomas and paragangliomas in humans and dogs.
Galac S; Korpershoek E
Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in diagnosis and treatment of pheochromocytoma.
Veglio F; Morello F; Morra Di Cella S; Del Colle S; Rabbia F; Mulatero P
Minerva Med; 2003 Aug; 94(4):267-71. PubMed ID: 14605591
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing for pheochromocytoma.
Karasek D; Frysak Z; Pacak K
Curr Hypertens Rep; 2010 Dec; 12(6):456-64. PubMed ID: 20938758
[TBL] [Abstract][Full Text] [Related]
37. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of pheochromocytoma.
Lenz T; Gossmann J; Schulte KL; Salewski L; Geiger H
Clin Lab; 2002; 48(1-2):5-18. PubMed ID: 11833676
[TBL] [Abstract][Full Text] [Related]
39. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma.
Ilias I; Yu J; Carrasquillo JA; Chen CC; Eisenhofer G; Whatley M; McElroy B; Pacak K
J Clin Endocrinol Metab; 2003 Sep; 88(9):4083-7. PubMed ID: 12970267
[TBL] [Abstract][Full Text] [Related]
40. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG; Martucci VL; Pacak K
Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
